Senior insider sale
EVP, GMDA at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$7.60M
16.72K shares
What this filing means
BOZIC CARMEN plans to sell 16.72K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $7.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/5/2026ACC: 0001959173-26-004391
Officer· EVP, GMDA
Since Oct 2019
16.72K
Shares to sell
$7.60M
Approx. market value
1.75K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/10/2026
1.75KTotal acquired1.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2026 | Restricted Stock Vesting Compensation | 1.75K | — |
| Total | 1.75K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
1.97K
Market value
$888.3K
5/29/2026
—Completed
Units to sell
1.35K
Market value
$614.0K
5/15/2026
—Completed
Units to sell
6.99K
Market value
$3.14M
5/12/2026
—Completed
Units to sell
2.33K
Market value
$1.05M
3/27/2026
—Completed
Units to sell
2.33K
Market value
$1.12M
3/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.75K
Market value
$785.3K
6/5/2026
Total
Units
16.72K
Value
$7.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/29/2026 | 1.97K | $888.3K | — | Completed |
5/15/2026 | 1.35K | $614.0K | — | Completed |
5/12/2026 | 6.99K | $3.14M | — | Completed |
3/27/2026 | 2.33K | $1.05M | — | Completed |
3/13/2026 | 2.33K | $1.12M | — | Completed |
| Planned — Approximate Date | ||||
6/5/2026 | 1.75K | $785.3K | NASDAQ | Planned |
| Total | 16.72K | $7.60M | ||